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Background: Ocular adnexal IgG4-related sclerosing disease (IgG4-SD) has been categorized as a novel disease
entity. It is characterized by stromal sclerosis and an infiltration of mass-forming lymphoplasmic cells containing
many IgG4-positive plasma cells. Although ocular adnexal tissue involvement has been increasingly reported, a
focal nodular sub-brow mass is not typical in an IgG4-SD presentation. We report a rare case of probable ocular
adnexal IgG4-SD that clinically mimicked eyelid pilomatrixoma.
Case presentation: A 42-year-old woman presented with a nodular mass in her left sub-brow area. The initial
clinical impression of her lesion was eyelid pilomatrixoma. However, the final pathologic diagnosis was IgG4–SD,
but extranodal marginal zone B-cell lymphoma could not be excluded. The patient underwent testing to determine tumor
malignancy and systemic IgG4-SD involvement. Laboratory testing showed normal IgG and IgG4 serum levels and imaging
revealed no remarkable findings. Oral prednisolone was administered and slowly tapered to manage the possible remnant
lesion and to prevent disease recurrence. Two years after initiating therapy, there was no evidence of relapse. The patient is
under close surveillance for signs of recurrence, systemic involvement, and potential malignant transformation.
Conclusions: We found an unusual case of probable ocular adnexal IgG4-SD, which presented as a unilateral restricted
mass involving the sub-brow area. Although the mass was surgically removed, systemic steroid treatment and long-term
surveillance were initiated due to the possibility of recurrence, the potential association with systemic disease, and the
potential development of extranodal mucosa-associated lymphoid tissue (MALT) lymphoma.
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Ocular adnexal IgG4-related sclerosing disease (IgG4-SD)
has been categorized as a novel disease entity that may
account for a certain proportion of idiopathic ocular and
periocular inflammatory lesions. It is characterized by stro-
mal sclerosis and an infiltration of mass-forming lympho-
plasmic cells containing many IgG4-positive plasma cells.
It can involve various organs including pancreas, bile duct,
retroperitoneal soft tissues, liver, thyroid, lung and salivary
glands, either singly or systematically [1,2]. Although the* Correspondence: hokyung214@gmail.com
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unless otherwise stated.prototype of IgG4-SD in ophthalmologic disorders is bilat-
eral dacryoadenitis accompanied by sialadenitis (formerly
termed Mikulicz disease), involvement of other ocular ade-
nexal tissues such as orbital fat, extraocular muscles, and
lacrimal sac has been increasingly reported in the literature
[3-5]. However, a focal nodular sub-brow mass is not typ-
ical in an IgG4-SD presentation. We report a rare case of
probable ocular adnexal IgG4-SD that clinically mimicked
eyelid pilomatrixoma.
Case presentation
A 42-year-old woman with no significant past medical his-
tory presented with a painless nodular mass in her left upper
lid, which had had slowly enlarged over 1 year. On clinical
examination, a non-tender, nodular mass (5.5 mm×4.5 mm)
was palpable in the left sub-brow region and was freely mo-
bile over subcutaneous tissue (Figure 1A). A diagnosis ofis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Clinical presentation. (A) Clinical photograph of a patient presenting with a 5.5 mm× 4.5 mm soft non-tender nodular mass with no
overlying skin change. (B) An orbital CT scan showing a 7-mm nodular homogenous enhancing mass adherent to the skin of the left upper lid (arrow).
Choi et al. BMC Ophthalmology  (2015) 15:23 Page 2 of 4presumed pilomatrixoma of the eyelid was made. Com-
puted tomography with contrast of the orbit showed a
7-mm nodular homogenous enhancing mass that was
adherent to the left upper lid skin (Figure 1B). This im-
plied that the tumor had originated from either skin or
a dermal appendage.
A total excisional biopsy was scheduled. Unfortunately,
the tumor’s infiltrative growth pattern made it difficult
to completely excise it from surrounding tissues. The
tumor was pinkish to brown in color, poorly circum-
scribed, and had a rubbery surface.
Histology revealed that the mass had a dense
lymphocytic infiltration with lymphoid follicles, mod-
erate plasma cell infiltration with a few eosinophils,
and interstitial fibrosis (Figure 2A, B). Immunohistol-
ogy showed increased CD20+ B-cells with slight
marginal zone expansion, focal CD3+ T cell infiltra-
tion, a polyclonal plasma cell population with an even
distribution of kappa and lambda light chains, and a
low Ki-67 proliferative index (5% of all lymphoid cells).
The number of IgG4+ plasma cells, counted in a high
power field (HPF: X10 eyepiece and x 40 objective
lenses), was >50 and the IgG4/IgG ratio was 50%Figure 2 Histopathology. Biopsied specimen shows lymphoid nodules and
Under higher magnification, interfollicular spaces are filled with plasma c
(C) Infiltration of IgG4-positive plasma cells numbered >50 in a high-pow(Figure 2C). The resulting final pathologic diagnosis
was inflammatory pseudotumor with increased IgG4+
plasma cells; possible association with IgG4-SD, but
extranodal marginal zone B-cell lymphoma could not
be excluded.
Therefore, the patient underwent testing to deter-
mine tumor malignancy and systemic IgG4-SD involve-
ment. Laboratory testing showed normal IgG and IgG4
serum levels. [1030 mg/dL (reference range, 700–1600),
21.1mg/dL (reference range, 6.1-121.4), respectively].
Serum Lactate dehydrogenase concentration was within
normal range. Except for a 3 cm sized uterine myoma,
imaging studies including chest CT, abdomen and pel-
vic CT, and positron emission tomography scanning
demonstrated no remarkable findings.
For the management of possible remnant lesion and
prevention of recurrence of disease, oral prednisolone
was administered at a 40 mg/day initial dose and was
slowly tapered to a 2.5 mg/day maintenance dose. One
year after initiating therapy, there was no evidence of
relapse. The patient is under close surveillance for signs
of recurrence, systemic involvement, and potential ma-
lignant transformation.interstitial fibrosis (A) hematoxylin-eosin staining, ×100 magnification).
ells and eosinophils (B) hematoxylin-eosin, magnification × 400).
er field (anti-IgG4 antibody, magnification × 400).
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Recognition of IgG4-SD is clinically important because
this disease is, theoretically, a systemic disorder. Steroid
therapy has been proposed to be effective, but relapse
occurs frequently. Furthermore, recent studies suggest
that IgG4+ plasma cells might be involved in the patho-
genesis of mucosa-associated lymphoid tissue (MALT)
lymphoma [6-8]. Moreover, many ocular adnexal MALT
lymphoma cases are wrongly categorized as IgG4-SD,
illustrating the difficulty of distinguishing between
MALT lymphoma and IgG4-SD [7,9,10]. In our case, the
lesion’s clinical appearance was typical of an eyelid pilo-
matixoma, a benign tumor originating from the hair
follicle matrix that occurs frequently in the sub-brow
area in the pediatric age group. Clinically, it appears as
a slowly enlarging, non tender nodular mass which is
freely movable over the subcutaneous tissue. The
present case demonstrates the importance of patho-
logic confirmation, even when clinical examination
suggests that a lesion is likely benign with clinically
typical presentation.
Two characteristics IgG4-SD include dense sclerosis
with abundant IgG4+ plasma cell infiltration and serum
IgG4 level elevation [1]. In this case, as the clinical find-
ing of unilateral focal subbrow mass was not typical
presentation of IgG4-SD, the autoantibody profile
including serum IgG4 level was not evaluated at initial
presentation. After the pathologic confirmation of IgG4-
SD, that is, two weeks after excisional biopsy, the post-
operative serum IgG4 levels were checked. The timing
of the measurement would be one of the possible expla-
nations of the normal serum IgG4 level of this patient,
as grossly no residual lesion existed postoperatively.
Even though there was no preoperative evidence of
serum IgG4 elevation in our patient, this case was given
a probable diagnosis of IgG4-SD of the ocular adnexa
based on the comprehensive diagnostic criteria for
IgG4-SD (See the ‘Comprehensive diagnostic criteria for
IgG4-related sclerosing disease’ section). It is true that
serum IgG4 levels are frequently elevated in patients
with IgG4-SD and this finding can be a useful diagnostic
tool, however, not all of the reported cases with IgG4-SD
revealed elevated serum IgG4 concentration [11-14].
Yamamoto et al. showed that high serum IgG4 levels are
not specific to IgG4-SD [14].
Comprehensive diagnostic criteria for IgG4-related
sclerosing disease, 2011
1. Clinical examination showing characteristic diffuse/
localized swelling or masses in single or multiple
organs
2. Hematological examination shows elevated serum
IgG4 concentrations( 135 mg/dl)3. Histopathologic examination shows:
(1)Marked lymphocyte and plasmacyte infiltration
and fibrosis.
(2)Infiltration of IgG4+ plasma cells: ratio of
IgG4+/IgG+ cells > 40% and >10 IgG4 + plasma
cells/HPF.
Definite: 1) + 2) + 3)
Probable: 1) + 3)
Possible: 1) + 2)Conclusions
We found an unusual case of probable ocular adnexal
IgG4-SD, which presented as a unilateral restricted mass
involving the sub-brow area. Although the mass was
surgically removed, systemic steroid treatment and long-
term surveillance was initiated due to the possibility of
recurrence, the potential association with systemic
disease, and the potential development of extranodal
MALT lymphoma.Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor of this journal.
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